Nathan R Wall
Overview
Explore the profile of Nathan R Wall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
2966
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perry C, Schulte R, Fuller R, Wall N, Nick K, Wegrzyn M, et al.
Biochim Biophys Acta Gen Subj
. 2025 Mar;
:130793.
PMID: 40086767
X-irradiation has extensive applications in therapy and considerable attention has been devoted to the radiosensitizing properties of nanoparticles composed of high atomic number elements, particularly gold. Low energy electrons and/or...
2.
Morcos A, Jung Y, Galvan Bustillos J, Fuller R, Caba Molina D, Bertucci A, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39409913
The duocarmycin family is a group of potent cytotoxic agents originally isolated from the bacterium Streptomyces. This discovery has spurred significant interest due to duocarmycins' unique chemical structures and powerful...
3.
Fuller R, Morcos A, Galvan Bustillos J, Caba Molina D, Wall N
Biochim Biophys Acta Rev Cancer
. 2024 Jul;
1879(5):189153.
PMID: 38986720
This review comprehensively investigates the intricate interplay between small non-coding RNAs (sncRNAs) and pancreatic ductal adenocarcinoma (PDAC), a devastating malignancy with limited therapeutic options. Our analysis reveals the pivotal roles...
4.
Fuller R, Vallejos P, Kabagwira J, Liu T, Wang C, Wall N
Front Genet
. 2024 Jun;
15:1393353.
PMID: 38919953
Chemotherapy resistance remains a significant challenge in the treatment of pancreatic adenocarcinoma (PDAC), particularly in relation to gemcitabine (Gem), a commonly used chemotherapeutic agent. MicroRNAs (miRNAs) are known to influence...
5.
Kabagwira J, Fuller R, Vallejos P, Sugiono C, Andrianarijaona V, Chism J, et al.
Onco Targets Ther
. 2024 Feb;
17:63-78.
PMID: 38313386
Introduction: Peritoneal metastases from colorectal cancer (CRC) present a significant clinical challenge with poor prognosis, often unresponsive to systemic chemotherapy. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is...
6.
Denes B, Fuller R, Kelin W, Levin T, Gil J, Harewood A, et al.
Vaccines (Basel)
. 2023 Dec;
11(12).
PMID: 38140268
Mucosal vaccines protect against respiratory virus infection by stimulating the production of IgA antibodies that protect against virus invasion of the mucosal epithelium. In this study, a novel protein subunit...
7.
Wall N, Fuller R, Morcos A, De Leon M
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894437
Pancreatic cancer (PCa) remains a formidable global health challenge, with high mortality rates and limited treatment options. While advancements in pharmacology have led to improved outcomes for various cancers, PCa...
8.
Ceja L, Escopete S, Hughes L, Lopez L, Camberos V, Vallejos P, et al.
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175796
New stem cell and extracellular-vesicle-based therapies have the potential to improve outcomes for the increasing number of patients with heart failure. Since neonates have a significantly enhanced regenerative ability, we...
9.
Vallejos P, Gonda A, Yu J, Sullivan B, Ostowari A, Kwong M, et al.
Ann Surg Oncol
. 2023 Mar;
30(6):3833-3844.
PMID: 36864326
Background: Liquid biopsies have become an integral part of cancer management as minimally invasive options to detect molecular and genetic changes. However, current options show poor sensitivity in peritoneal carcinomatosis...
10.
Fuller R, Kabagwira J, Vallejos P, Folkerts A, Wall N
Onco Targets Ther
. 2022 Oct;
15:1147-1160.
PMID: 36238134
Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with poor prognosis, as it is difficult to predict or circumvent, and it develops chemoresistance quickly. One cellular mechanism associated...